 The stock price of Inovio Pharmaceuticals, a biotechnology company focused on synthetic DNA products for treating cancers and infectious diseases, has seen a large fall of 17 over the last month, while it is down 8 over the last week. This can be attributed to the spread of the new Covid-19. 